1921
Volume 75, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Just more than 2,000 cases of malaria are reported in the United Kingdom annually, with a mortality rate of approximately 1%. Some studies suggest that patients with malaria who originate from disease-endemic areas are less likely to develop severe disease; such patients are often treated at home. We have prospectively examined 99 patients with imported malaria and categorized them according to severity as defined by World Health Organization criteria. There was no significant difference between those who developed severe disease and those who did not in terms of their ethnicity, residence in a malaria-endemic area, or history of previous episodes of malaria. To assume a patient has clinical immunity to malaria simply because they originate from or have lived for a long time in a malaria-endemic area may be inappropriate and unsafe.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2006.75.1195
2006-12-01
2017-09-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/75/6/0751195.html?itemId=/content/journals/10.4269/ajtmh.2006.75.1195&mimeType=html&fmt=ahah

References

  1. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster, 2000. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1–S90.
  2. Bradley DJ, Warhust DC, Blaze M, Smith V, Williams J, 1998. Malaria imported into the United Kingdom in 1996. Euro Surveill 3 : 40–42.
  3. D’Acremont V, Landry P, Darioli R, Stuerchler D, Pecoud A, Genton B, 2002. Treatment of imported malaria in an ambulatory setting: a prospective study. BMJ 324 : 875–877.
  4. Marsh K, 2002. Immunology of malaria. Warrell DA, Gilles HM, eds. Essential Malariology. Fourth edition. London: Arnold, 252–267.
  5. Kain KC, Harrington MA, Tennyson S, Keystone JS, 1998. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 27 : 142–149.
  6. Jensenius M, Rønning EJ, Blystad H, Bjørneklett A, Hellum KB, Bucher A, Haheim LL, Myrvang B, 1999. Low frequency of complications in imported falciparum malaria: a review of 222 cases in south-eastern Norway. Scand J Infect Dis 31 : 73–78.
  7. Bouchaud O, Cot M, Kony S, Durand R, Schiemann R, Ralaimazava P, Coulaud J-P, Le Bras J, Deloran P, 2005. Do African immigrants living in France have long-term malarial immunity? Am J Trop Med Hyg 72 : 21–25.
  8. Chaput De Saintonge DM, Vere DW, 1974. Why don’t doctors use cusums? Lancet i : 120–121.
  9. Rhee MS, Akannmori BD, Waterfall M, Riley EM, 2001. Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria. Clin Exp Immunol 126 : 503–510.
  10. Dodoo D, Omer F, Todd J, Akanmori BD, Koram KA, Riley EM, 2002. Absolute levels and ratios of pro-inflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to P. falciparum malaria. J Infect Dis 185 : 971–979.
  11. Struik S, Riley EM, 2004. Does malaria suffer from lack of memory? Immunol Rev 201 : 268–290.
  12. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, White NJ, Ho M, 1999. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis 180 : 1288–1297.
  13. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH, 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 320 : 1586–1591.
  14. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM, 1990. TNF concentration in fatal, non-fatal cerebral and uncomplicated Plasmodium falciparum malaria. Lancet 336 : 1201–1204.
  15. May J, Lell B, Luty AJ, Meyer CG, Kremsner PG, 2000. Plasma interleukin-10:tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis 182 : 1570–1573.
  16. Kwiatkowski D, Bate CA, Scragg IG, Beattie P, Udalova I, Knight JC, 1997. The malaria fever response – pathogenesis, polymorphism and prospects for intervention. Ann Trop Med Parasitol 91 : 533–542.
  17. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro I, Malima R, Lusingu JP, Manjurano A, Nkya WMMM, Lemnge MM, Cox J, Reyburn HG, Riley EM, 2005. Estimating medium and long terms trends in malaria transmission using serological markers of malaria exposure. Proc Natl Acad Sci USA 102 : 108–113.
  18. Artavanis-Tsakonas K, Tongren JE, Riley EM, 2003. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin Exp Immunol 133 : 145–152.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2006.75.1195
Loading
/content/journals/10.4269/ajtmh.2006.75.1195
Loading

Data & Media loading...

  • Received : 24 May 2006
  • Accepted : 02 Aug 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error